| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $233.2M | +60.5% |
| Cost of Revenue | $7.7M | -32.4% |
| R&D Expense | $217.5M | -11.2% |
| SG&A Expense | $264.1M | -0.5% |
| Operating Income | -$323.8M | +16.6% |
| Pre-tax Income | -$320.5M | +14.8% |
| Income Tax | $120K | -46.2% |
| Net Income | -$321.5M | -188.6% |
| EPS (Basic) | -$4.08 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $58.5M | +0.6% |
| Accounts Receivable | $27.1M | +28.0% |
| Inventory | $6.2M | -34.1% |
| Current Assets | $416.7M | -32.4% |
| Total Assets | $594.1M | -24.7% |
| Current Liabilities | $200.8M | +12.8% |
| Total Liabilities | $535.0M | -9.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$237.5M | +15.2% |
| Investing Cash Flow | $99.3M | +78.1% |
| Financing Cash Flow | $139.4M | -36.3% |
| -172.0% |
| EPS (Diluted) | -$4.08 | -172.0% |
| Stockholders' Equity |
| $59.1M |
| -70.6% |